Brief: Oncolys Biopharma signs joint research agreement for next generation telomelysin with Osaka University
28/03/2017 07:25
March 28 (Reuters) - Oncolys Biopharma Inc 4588.T :
* Says it signed a joint research agreement for design and
production of next generation telomer ricin and next generation
telome scan with Osaka University
Source text in Japanese: https://goo.gl/PdVgvK
Further company coverage: 4588.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com;)(+86 010
62674724;)(Reuters
Messaging:)(shuai.liu.reuters.com@reuters.net))